Jeil Pharma Holdings Inc

₩6,800As of Sun 8 Nov 2026, 12:00 UTC
KRX:002620Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (10.61%)
Div yield 1.03%
ROE 5.55%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.44
PE TTM 12.39
TSR TTM (15.74%)
Mkt cap ₩104.4B
ROIC 3.30%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩7,459
9.70%
(48.60%)
Buy 5|2|8|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
83.55
88.21
86.88
82.75
15.74%
21.72%
15.46%
10.45%
Revenue₩B
7.403
7.836
7.844
7.915
15.39%
19.75%
16.91%
12.26%
Peers (US$76.96M)
Cap (US$)
PE
79.31M
—
77.47M
731.9x
Capital
TTM
5Y
10Y
Leveragex
0.940
0.075
0.063
EBIT/Intx
1.555
0.222
0.194
Own earn%
49.26
(124.00)
(119.72)
Sh yield%
38.31
40.82
40.83
Owners
Insiders/Inst%
2.28
31.09
Short interest%
5.09
SBC / revenue%
5.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–5
$1 testx
0.1
Incr. ROIC%
13